425 related articles for article (PubMed ID: 26817932)
1. Advanced glycation end products are elevated in cystic fibrosis-related diabetes and correlate with worse lung function.
Hunt WR; Helfman BR; McCarty NA; Hansen JM
J Cyst Fibros; 2016 Sep; 15(5):681-8. PubMed ID: 26817932
[TBL] [Abstract][Full Text] [Related]
2. The role of receptor for advanced glycation end products in airway inflammation in CF and CF related diabetes.
Mulrennan S; Baltic S; Aggarwal S; Wood J; Miranda A; Frost F; Kaye J; Thompson PJ
Sci Rep; 2015 Mar; 5():8931. PubMed ID: 25754382
[TBL] [Abstract][Full Text] [Related]
3. Higher levels of the soluble receptor for advanced glycation end products and lower levels of the extracellular newly identified receptor for advanced glycation end products were associated with lipid-lowering drugs in patients with type 1 diabetes: a comparative cross-sectional study.
Melin EO; Dereke J; Hillman M
Lipids Health Dis; 2020 Oct; 19(1):223. PubMed ID: 33054750
[TBL] [Abstract][Full Text] [Related]
4. The Receptor for Advanced Glycation End Products (Rage) and Its Ligands in Plasma and Infrainguinal Bypass Vein.
Malmstedt J; Frebelius S; Lengquist M; Jörneskog G; Wang J; Swedenborg J
Eur J Vasc Endovasc Surg; 2016 Apr; 51(4):579-86. PubMed ID: 26905625
[TBL] [Abstract][Full Text] [Related]
5. Elevated Circulating S100A12 Associates with Vascular Disease and Worse Clinical Outcome in Peritoneal Dialysis Patients.
Isoyama N; Machowska A; Qureshi AR; Yamamoto T; Anderstam B; Heimburger O; Barany P; Stenvinkel P; Lindholm B
Perit Dial Int; 2016; 36(3):269-76. PubMed ID: 26493750
[TBL] [Abstract][Full Text] [Related]
6. Systemic RAGE ligands are upregulated in tuberculosis individuals with diabetes co-morbidity and modulated by anti-tuberculosis treatment and metformin therapy.
Kumar NP; Moideen K; Nancy A; Viswanathan V; Shruthi BS; Sivakumar S; Hissar S; Kornfeld H; Babu S
BMC Infect Dis; 2019 Dec; 19(1):1039. PubMed ID: 31818258
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of advanced glycation end-products (AGEs) and the decoy soluble receptor for AGEs (sRAGE) can identify non-alcoholic fatty liver disease in age-, sex- and BMI-matched normo-glycemic adults.
Palma-Duran SA; Kontogianni MD; Vlassopoulos A; Zhao S; Margariti A; Georgoulis M; Papatheodoridis G; Combet E
Metabolism; 2018 Jun; 83():120-127. PubMed ID: 29409822
[TBL] [Abstract][Full Text] [Related]
8. Soluble Forms and Ligands of the Receptor for Advanced Glycation End-Products in Patients with Acute Respiratory Distress Syndrome: An Observational Prospective Study.
Jabaudon M; Blondonnet R; Roszyk L; Pereira B; Guérin R; Perbet S; Cayot S; Bouvier D; Blanchon L; Sapin V; Constantin JM
PLoS One; 2015; 10(8):e0135857. PubMed ID: 26274928
[TBL] [Abstract][Full Text] [Related]
9. Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein.
Basta G; Sironi AM; Lazzerini G; Del Turco S; Buzzigoli E; Casolaro A; Natali A; Ferrannini E; Gastaldelli A
J Clin Endocrinol Metab; 2006 Nov; 91(11):4628-34. PubMed ID: 16926247
[TBL] [Abstract][Full Text] [Related]
10. Continuous glucose monitoring and advanced glycation endproducts for prediction of clinical outcomes and development of cystic fibrosis-related diabetes in adults with CF.
Scully KJ; Brenner L; Martin K; Ruazol M; Sawicki GS; Uluer A; Neuringer I; Yonker LM; Sicilian L; Putman MS
Front Endocrinol (Lausanne); 2024; 15():1293709. PubMed ID: 38379863
[TBL] [Abstract][Full Text] [Related]
11. Circulating levels of soluble receptor for advanced glycation end products and ligands of the receptor for advanced glycation end products in patients with acute liver failure.
Basta G; Del Turco S; Navarra T; Lee WM;
Liver Transpl; 2015 Jun; 21(6):847-54. PubMed ID: 25825217
[TBL] [Abstract][Full Text] [Related]
12. Plasma S100A12 and soluble receptor of advanced glycation end product levels and mortality in chronic kidney disease Stage 5 patients.
Isoyama N; Leurs P; Qureshi AR; Bruchfeld A; Anderstam B; Heimburger O; Bárány P; Stenvinkel P; Lindholm B
Nephrol Dial Transplant; 2015 Jan; 30(1):84-91. PubMed ID: 25074436
[TBL] [Abstract][Full Text] [Related]
13. Effect of Vitamin D Receptor Activation on the AGE/RAGE System and Myeloperoxidase in Chronic Kidney Disease Patients.
Torino C; Pizzini P; Cutrupi S; Tripepi R; Vilasi A; Tripepi G; Mallamaci F; Zoccali C
Oxid Med Cell Longev; 2017; 2017():2801324. PubMed ID: 29362665
[TBL] [Abstract][Full Text] [Related]
14. The Relationship between Plasma Soluble Receptor for Advanced Glycation End Products and Coronary Artery Disease.
Wang X; Xu T; Mungun D; Zhou C; Zha Z; Lu M; Fen C; Guo Y
Dis Markers; 2019; 2019():4528382. PubMed ID: 31275446
[TBL] [Abstract][Full Text] [Related]
15. Association of four differently processed diets with plasma and urine advanced glycation end products and serum soluble receptor for advanced glycation end products concentration in healthy dogs.
Bridglalsingh S; Archer-Hartmann S; Azadi P; Barbier de La Serre C; Remillard RL; Sunvold GD; Bartges JW
J Anim Physiol Anim Nutr (Berl); 2024 May; 108(3):735-751. PubMed ID: 38279966
[TBL] [Abstract][Full Text] [Related]
16. Effect of circulating soluble receptor for advanced glycation end products (sRAGE) and the proinflammatory RAGE ligand (EN-RAGE, S100A12) on mortality in hemodialysis patients.
Nakashima A; Carrero JJ; Qureshi AR; Miyamoto T; Anderstam B; Bárány P; Heimbürger O; Stenvinkel P; Lindholm B
Clin J Am Soc Nephrol; 2010 Dec; 5(12):2213-9. PubMed ID: 20847094
[TBL] [Abstract][Full Text] [Related]
17. Accumulation of advanced glycation end products (AGEs) is associated with the severity of aortic stenosis in patients with concomitant type 2 diabetes.
Kopytek M; Ząbczyk M; Mazur P; Undas A; Natorska J
Cardiovasc Diabetol; 2020 Jun; 19(1):92. PubMed ID: 32552684
[TBL] [Abstract][Full Text] [Related]
18. [Correlation of the expressions of advanced glycation end products and its receptor in serum and placenta with the pathogenesis of preeclampsia].
Xian N; Chen W; Zhang Y; Li J; Zhang N; Ye Y
Zhonghua Fu Chan Ke Za Zhi; 2015 Jul; 50(7):493-9. PubMed ID: 26311638
[TBL] [Abstract][Full Text] [Related]
19. Associations between Soluble Receptor for Advanced Glycation End Products (sRAGE) and S100A12 (EN-RAGE) with Mortality in Long-term Hemodialysis Patients.
Jung ES; Chung W; Kim AJ; Ro H; Chang JH; Lee HH; Jung JY
J Korean Med Sci; 2017 Jan; 32(1):54-59. PubMed ID: 27914132
[TBL] [Abstract][Full Text] [Related]
20. Cystic-fibrosis related-diabetes (CFRD) is preceded by and associated with growth failure and deteriorating lung function.
Terliesner N; Vogel M; Steighardt A; Gausche R; Henn C; Hentschel J; Kapellen T; Klamt S; Gebhardt J; Kiess W; Prenzel F
J Pediatr Endocrinol Metab; 2017 Aug; 30(8):815-821. PubMed ID: 28245190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
